Clinical Trials Directory

Trials / Terminated

TerminatedNCT00230490

Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
150 (planned)
Sponsor
Bausch Health Americas, Inc. · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Compare the long-term safety of pradefovir to adefovir dipivoxyl

Detailed description

* Compare the long-term safety of pradefovir to adefovir dipivoxyl * Monitor development of resistance * Evaluate virologic and biochemical response

Conditions

Interventions

TypeNameDescription
DRUGpradefovir mesylate
DRUGadefovir dipivoxyl

Timeline

Start date
2005-06-01
Completion
2007-05-01
First posted
2005-09-30
Last updated
2019-11-29

Source: ClinicalTrials.gov record NCT00230490. Inclusion in this directory is not an endorsement.

Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201 (NCT00230490) · Clinical Trials Directory